Prenatal n-3 long-chain fatty acid status and offspring metabolic health in early and mid-childhood: results from Project Viva.

about

Prenatal n-3 long-chain fatty acid status and offspring metabolic health in early and mid-childhood: results from Project Viva.

Item

http://www.wikidata.org/entity/Q54962589

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Prenatal n-3 long-chain fatty ...... od: results from Project Viva.

@en

Prenatal n-3 long-chain fatty ...... od: results from Project Viva.

@nl

type

Item

label

Prenatal n-3 long-chain fatty ...... od: results from Project Viva.

@en

Prenatal n-3 long-chain fatty ...... od: results from Project Viva.

@nl

prefLabel

Prenatal n-3 long-chain fatty ...... od: results from Project Viva.

@en

Prenatal n-3 long-chain fatty ...... od: results from Project Viva.

@nl

P1476

Prenatal n-3 long-chain fatty ...... ood: results from Project Viva

@en

P2093

Emily Oken

http://www.w3.org/2001/XMLSchema#string

Matthew W Gillman

http://www.w3.org/2001/XMLSchema#string

Sheryl L Rifas-Shiman

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Longitudinal associations of sleep curtailment with metabolic risk in mid-childhood.

Adiponectin and leptin trajectories in Mexican-American children from birth to 9 years of age

Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: an open-label randomized controlled trial.

Construct validity of a continuous metabolic syndrome score in children.

Adiponectin: a link between excess adiposity and associated comorbidities?

Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico

Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort

P2888

s41387-018-0040-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41387-018-0040-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sjurdur F Olsen

Ekaterina Maslova

P577

2018-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29795533

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid

P932

5968023

http://www.w3.org/2001/XMLSchema#string